MRP8/MRP14 HETERODIMER, OR ITS INDIVIDUAL COMPONENTS IN COMBINATION, FOR TREATING AND/OR PREVENTING SKIN DISEASES, WOUNDS AND/OR WOUNDHEALING DISTURBANCES WHICH ARE CHARACTERIZED BY A REDUCED QUANTITY OF MRP8/MRP14 HETERODIMERS

Details for Australian Patent Application No. 2002304710 (hide)

Owner SWITCH BIOTECH AG

Inventors HALLE, Jorn-Peter; GOPPELT, Andreas

Pub. Number AU-A-2002304710

PCT Number PCT/EP02/04765

PCT Pub. Number WO2002/088181

Priority 101 21 254.2 30.04.01 DE; 60/322,925 17.09.01 US

Filing date 30 April 2002

Wipo publication date 11 November 2002

International Classifications

C07K 014/435 Peptides having more than 20 amino acids - from animals

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 101 21 254.2 30.04.01 DE; 60/322,925 17.09.01 US

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2002304710

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002304711-Gene expression in plastids based on replicating vectors

2002304709-METHOD OF DISPLAYING A SEQUENCE OF VIDEO IMAGES ON A PLASMA DISPLAY PANEL